ArticleJournal of extracellular vesicles2021
Dissemination of
Open access · goldAbstract read
In one paragraph
Article in Journal of extracellular vesicles, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 17 citations in OpenAlex.
- Screening of SIGLEC1 based on transcriptomics and investigation of its function and mechanism in regulating mycobacterium tuberculosis-induced injury and polarization in THP-1 macrophages.Archives of microbiology · 2026Article
- Extracellular Vesicles of Mycobacterium tuberculosis Serve as a Virulence Factor - Current Research Applications.Current microbiology · 2026Review
- The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomas.Nature immunology · 2026Article
- Role of myeloid cells expressing CD169/Siglec-1 in host-pathogen interactions.FEMS microbiology reviews · 2026Review
- Siglecs: From Biomodulation to Immunotherapy.Current protein & peptide science · 2026Review
- T cell-macrophage interactions in tuberculosis: What we've got here is failure to communicate.Journal of internal medicine · 2026Review
- Proteomics of blood extracellular vesicles in inflammatory respiratory diseases for biomarker discovery and new insights into pathophysiology.Inflammation and regeneration · 2024Review
- Construction of a panoramic mRNA map of adult noncystic fibrosis bronchiectasis and a preliminary study of the underlying molecular mechanisms.European journal of medical research · 2024Article
- Plitidepsin as an Immunomodulator against Respiratory Viral Infections.Journal of immunology (Baltimore, Md. : 1950) · 2024Article
- Extracellular Vesicles and Their Role in Lung Infections.International journal of molecular sciences · 2023Review
- Article
- Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.Frontiers in medicine · 2022Review
- Pathological and protective roles of dendritic cells inFrontiers in cellular and infection microbiology · 2022Review
- Immune Privilege Furnishes a Niche for Latent Infection.Frontiers in ophthalmology · 2022Review
- HIV-1Pathogens (Basel, Switzerland) · 2021Review
- Dissemination ofJournal of extracellular vesicles · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors at 13 institutions in 8 countries.
Susana BenetDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Cristina GálvezDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Francis DrobniewskiDepartment of Retrovirology Imperial College London UK.
Irina KontsevayaDepartment of Retrovirology Imperial College London UK.
Lilibeth AriasExperimental Tuberculosis Unit (UTE) Germans Trias i Pujol Health Science Research Institute Can Ruti Campus Badalona Spain.
Marta Monguió-TortajadaREMAR-IVECAT Group Germans Trias i Pujol Health Science Research Institute Can Ruti Campus Badalona Spain.
Itziar ErkiziaDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Victor UrreaDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Ruo-Yan OngDivision of Cell Signalling and Immunology University of Dundee Dundee UK.
Marina LuquinDepartament de Genètica i de Microbiologia Facultat de Biociències Universitat Autònoma de Barcelona Cerdanyola del Vallès Spain.
Maeva DupontInstitut de Pharmacologie et Biologie Structurale IPBS CNRS UPS Université de Toulouse Toulouse France.
Jakub ChojnackiDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Judith DalmauDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Paula CardonaExperimental Tuberculosis Unit (UTE) Germans Trias i Pujol Health Science Research Institute Can Ruti Campus Badalona Spain.
Olivier NeyrollesInstitut de Pharmacologie et Biologie Structurale IPBS CNRS UPS Université de Toulouse Toulouse France.
Geanncarlo Lugo-VillarinoInstitut de Pharmacologie et Biologie Structurale IPBS CNRS UPS Université de Toulouse Toulouse France.
Christel VérolletInstitut de Pharmacologie et Biologie Structurale IPBS CNRS UPS Université de Toulouse Toulouse France.
Esther JuliánDepartament de Genètica i de Microbiologia Facultat de Biociències Universitat Autònoma de Barcelona Cerdanyola del Vallès Spain.
Hansjakob FurrerDepartment of Infectious Diseases Bern University Hospital University of Bern Bern Switzerland.
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology University Hospital Zurich Zurich Switzerland.
Paul R CrockerDivision of Cell Signalling and Immunology University of Dundee Dundee UK.
Gustavo TapiaDepartment of Retrovirology Universitat Autònoma de Barcelona Cerdanyola del Vallès Spain.
Francesc E BorràsREMAR-IVECAT Group Germans Trias i Pujol Health Science Research Institute Can Ruti Campus Badalona Spain.
Jacques FellaySchool of Life Sciences École Polytechnique Fédérale de Lausanne Lausanne Switzerland.
Paul J McLarenJC Wilt Infectious Diseases Research Centre Public Health Agency of Canada Winnipeg Manitoba Canada.
Amalio TelentiThe Scripps Research Institute La Jolla California USA.
Pere-Joan CardonaExperimental Tuberculosis Unit (UTE) Germans Trias i Pujol Health Science Research Institute Can Ruti Campus Badalona Spain.
Bonaventura ClotetDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Cristina VilaplanaExperimental Tuberculosis Unit (UTE) Germans Trias i Pujol Health Science Research Institute Can Ruti Campus Badalona Spain.
Javier Martinez-PicadoDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.
Nuria Izquierdo-UserosDepartment of Retrovirology IrsiCaixa AIDS Research Institute Badalona Spain.ORCID 0000-0002-1039-1821
Universitat Autònoma de Barcelona · ESIrsiCaixa · ESCentre National de la Recherche Scientifique · FRUniversitat de Vic - Universitat Central de Catalunya · ESUniversity of Dundee · GBImperial College London · GBInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESPublic Health Agency of Canada · CAResearch Center Borstel - Leibniz Lung Center · DEScripps Research Institute · USSIB Swiss Institute of Bioinformatics · CHUniversity of Bern · CHUniversity of Zurich · CH
Funding
Wellcome Trust 103744/Z/14/Z
Abstract
The identification of individuals with null alleles enables studying how the loss of gene function affects infection. We previously described a non-functional variant in
Indexed as
AnimalsAntigen PresentationExtracellular VesiclesHumansImmunityLungMiceMycobacterium tuberculosisSialic Acid Binding Ig-like Lectin 1Tuberculosis, Lymph NodeTuberculosis, PulmonarySialic Acid Binding Ig-like Lectin 1Siglec1 protein, mouseExtracellular vesiclesHIV‐1MtbSiglec‐1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.